In patients with extrahepatic cholangiocarcinoma who have undergone R0 resection, do you routinely offer adjuvant chemotherapy?
If so, which agent(s) do you prefer?
Answer from: Medical Oncologist at Community Practice
Two recent studies have addressed the role of adjuvant therapy in patients with extrahepatic cholangiocarcinoma.1. SWOG 0809 exclusively enrolled extrahepatic CC patients only. This was a single arm study that treated patients with a combination of chemotherapy (capecitabine + Gemcitabine) followed ...